Clinical trialsRegistry-verifiedHospital-route model
Etablissement Public De Sante Barthelemy Durand
Etampes Cedex, France
Treatment & access
- Treatments offeredKetamine
- Access routeTrial
- Cost & coverage (registry status)Free within clinical trial
- Websitehttps://www.eps-barthelemy-durand.fr/
About this provider
This entry describes a clinical trial site: Etablissement Public De Sante Barthelemy Durand, Etampes Cedex, France. The site takes part in CTIS trial 2023-506597-12-00, the MOODBOOSTER trial on early efficacy of ketamine compared to placebo, added to venlafaxine, for inpatients with severe unipolar major depressive episodes (sponsor: Assistance Publique Hopitaux De Paris). The treatment studied is ketamine; access runs through enrolment in the trial, and participation is free of charge within it. The CTIS public record in the EU Clinical Trials Information System is the registry source cited. Last verification of this entry: 2026-08-02.
Verification
- License / registryCTIS (EU Clinical Trials Information System)
- Official registryhttps://euclinicaltrials.eu/ctis-public/view/2023-506597-12-00
- Last verified
Check your fit & enquire
Check my fit & enquireWhat to prepare before you enquire
- A referral or the contact details of your treating clinician
- A list of medications you have tried (names, doses, duration)
- A short diagnosis summary or discharge letters